Q1 2021 Aurinia Pharmaceuticals Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to Aurinia Pharmaceuticals First Quarter 2021 Financial Results Conference event. (Operator Instructions)
It is now my pleasure to turn the floor over to your host, Glenn Schulman. Sir, the floor is yours.
Thanks, Matthew, and good afternoon, everyone. I'm pleased to welcome you to today's call discussing Aurinia's first quarter financial results. Joining me on the call this afternoon are Peter Greenleaf, our President and CEO; Max Colao, Chief Commercial Officer; Neil Solomons, Chief Medical Officer; and Joe Miller, our Chief Financial Officer.
This afternoon, after the close, we issued a press release announcing our financial results and recent operational highlights, which is accessible from our website at www.auriniapharma.com, and has been filed on Form 8-K with the SEC as well. We also filed our financial statement and management's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |